title: Insulin-like factor 3 plasma levels in acromegaly before and after somatostatin analog treatment.
authors.affiliation: Department of Medicine-DIMED, Clinica Medica 3, University of Padova, School of Medicine, Via Giustiniani 2, 35128, Padova, Italy, marco.rossato@unipd.it.
authors.forename: Marco
authors.initials: M
authors.lastname: Rossato
authors.forename: Francesca
authors.initials: F
authors.lastname: Dassie
authors.forename: Valentina
authors.initials: V
authors.lastname: Silvestrin
authors.forename: Chiara
authors.initials: C
authors.lastname: Martini
authors.forename: Roberto
authors.initials: R
authors.lastname: Vettor
authors.forename: Pietro
authors.initials: P
authors.lastname: Maffei
mesh_terms: D000172:Acromegaly / Q000097:blood* / Q000188:drug therapy*; D000328:Adult; D005260:Female; D019382:Human Growth Hormone / Q000187:drug effects / Q000378:metabolism*; D006801:Humans; D007328:Insulin / Q000097:blood*; D008297:Male; D010456:Peptides, Cyclic / Q000008:administration & dosage / Q000494:pharmacology*; D011506:Proteins / Q000187:drug effects; D013004:Somatostatin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology*
chemical_list: D007328:Insulin; C084797:Leydig insulin-like protein; D010456:Peptides, Cyclic; D011506:Proteins; C060347:lanreotide; D019382:Human Growth Hormone; D013004:Somatostatin